SYNIMMUNE Competitors and Similar CompaniesClear all

SYNIMMUNE's competitors and similar companies include Allogene Therapeutics.
SYNIMMUNE
SYNIMMUNE
SYNIMMUNE is a biotechnology company dedicated to the development of mono- and bispecific anti-tumor antibodies.
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
Founding Date
Founding Date
2010
Founding Date
2018
Type
Type
Private
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Locations
South San Francisco, US HQ
Employees
Employees
5
Employees
2263% decrease
For sources of this data, please see the company profile

View Company Profiles

Allogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease

Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.

View company